AcelRx Pharmaceuticals, Inc.

Q2 2023 13F Holders

Symbol
TLPH
CUSIP
00444T209
Type
Equity
Class
COM NEW
Num filings
29
Total reported value, excl. options
$1.17 M
Manager Report Date Value ($000) Shares Option Type